Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Elevated estradiol and testosterone levels and risk for breast cancer.

    Yu H, Diamandis EP, Hoffman B.

    Ann Intern Med. 1999 Nov 2;131(9):715. No abstract available. PMID: 10577342 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.

    Tamimi RM, Byrne C, Colditz GA, Hankinson SE.

    J Natl Cancer Inst. 2007 Aug 1;99(15):1178-87. Epub 2007 Jul 24.PMID: 17652278 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study.

    Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM, Cauleys JA.

    Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1047-51.PMID: 15894651 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.

    J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.PMID: 16418513 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men.

    Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, Chen CJ.

    J Natl Cancer Inst. 2001 Nov 7;93(21):1644-51.PMID: 11698569 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Plasma sex steroid hormones and breast cancer risk in Chinese women.

    Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT, Li BD, Zheng W.

    Int J Cancer. 2003 May 20;105(1):92-7.PMID: 12672036 [PubMed - indexed for MEDLINE]Related articles

    7.

    Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

    J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.PMID: 15601642 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Serum testosterone levels and breast cancer recurrence.

    Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A, Berselli E, Muti P, Secreto G.

    Int J Cancer. 2005 Jan 20;113(3):499-502.PMID: 15455345 [PubMed - indexed for MEDLINE]Related articles

    9.

    Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.

    Kahán Z, Gardi J, Nyári T, Földesi I, Hajnal-Papp R, Ormándi K, Lázár G, Thurzó L, Schally AV.

    Int J Oncol. 2006 Jul;29(1):193-200.PMID: 16773200 [PubMed - indexed for MEDLINE]Related articles

    10.

    Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).

    Manjer J, Johansson R, Berglund G, Janzon L, Kaaks R, Agren A, Lenner P.

    Cancer Causes Control. 2003 Sep;14(7):599-607.PMID: 14575357 [PubMed - indexed for MEDLINE]Related articles

    11.

    An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivors.

    Fan J, McKean-Cowdin R, Bernstein L, Stanczyk FZ, Li AX, Ballard-Barbash R, McTiernan A, Baumgartner R, Gilliland F.

    Breast Cancer Res Treat. 2006 Oct;99(3):323-31. Epub 2006 Jun 5.PMID: 16752222 [PubMed - indexed for MEDLINE]Related articles

    12.

    UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients.

    Sparks R, Ulrich CM, Bigler J, Tworoger SS, Yasui Y, Rajan KB, Porter P, Stanczyk FZ, Ballard-Barbash R, Yuan X, Lin MG, McVarish L, Aiello EJ, McTiernan A.

    Breast Cancer Res. 2004;6(5):R488-98. Epub 2004 Jun 29.PMID: 15318931 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?

    Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE.

    J Clin Oncol. 2006 Apr 20;24(12):1823-30. Epub 2006 Mar 27.PMID: 16567770 [PubMed - indexed for MEDLINE]Related articles

    14.

    Polymorphisms associated with circulating sex hormone levels in postmenopausal women.

    Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA.

    J Natl Cancer Inst. 2004 Jun 16;96(12):936-45.PMID: 15199113 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).

    Sturgeon SR, Potischman N, Malone KE, Dorgan JF, Daling J, Schairer C, Brinton LA.

    Cancer Causes Control. 2004 Feb;15(1):45-53.PMID: 14970734 [PubMed - indexed for MEDLINE]Related articles

    16.

    Endogenous hormones and risk of breast cancer in postmenopausal women.

    Hankinson SE.

    Breast Dis. 2005-2006;24:3-15. Review.PMID: 16917136 [PubMed - indexed for MEDLINE]Related articles

    17.

    Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.

    Hietala M, Sandberg T, Borg A, Olsson H, Jernström H.

    Hum Reprod. 2007 Jan;22(1):83-91. Epub 2006 Aug 18.PMID: 16920725 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.

    J Natl Cancer Inst. 2005 May 18;97(10):755-65.PMID: 15900045 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

    J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.PMID: 15840882 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.

    Yu H, Shu XO, Li BD, Dai Q, Gao YT, Jin F, Zheng W.

    Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1067-73.PMID: 14578144 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data